| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.35 | 8e-07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-06 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-05 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0002 |